Abstract
Levels of D‐dimer and fibrinogen/fibrin degradation products (FDPs) are significantly elevated in patients with deep venous thrombosis, pulmonary embolism, disseminated intravascular coagulation, or other complications. The diagnosis of these disorders can be difficult, time‐consuming, and expensive. Assays for the detection of FDPs and D‐dimer are used in many laboratories to investigate these disorders. The aim of this study was to compare plasma D‐dimer levels obtained by the immuno‐turdimetric method (Liatest D‐Dimer Diagnostica Stago, Asnières, France) with plasma FDPs were measured by latex agglutination to investigate the relationship between these parameters. These immunoassays were tested in 144 blood samples from patients with suspected disorders associated with activation of coagulation or fibrinolytic systems. D‐dimer and FDPs assays were performed in plasma samples by the use of Liatest D‐dimer and plasma FDPs (Diagnostica Stago), respectively. Patients were divided into four groups according to plasma D‐dimer levels. In group 1, 47.4% had negative FDPs and 52.6% had positive FDPs. In group 2, 15.4% had negative FDPs and 84.6% had positive FDPs. In group 3, 10.3% had negative FDPs and 89.7% had positive FDPs. All of the patients in group 4 had positive FDPs. It was shown that plasma D‐dimer levels measured by Liatest D‐dimer have a relation to FDP levels measured by latex agglutination. J. Clin. Lab. Anal. 17:77–79, 2003. © 2003 Wiley‐Liss, Inc.
Keywords: hemostasis, D‐dimer, fibrinogen/fibrin degradation products, fibrinolysis, immunoassays
REFERENCES
- 1. Rowe CA, Bolitho JS, Jane A, et al. Rapid detection of D‐dimer using a fiber optic biosensor. Thromb Haemost 1998;79:94–98. [PubMed] [Google Scholar]
- 2. Kearon C, Ginsberg JS, Douketis J, et al. Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D‐dimer testing. Ann Intern Med 2001;135:108–111. [DOI] [PubMed] [Google Scholar]
- 3. Kovacs MJ, MacKinnon KM, Anderson D, et al. A comparison of three rapid D‐dimer methods for the diagnosis of venous thromboembolism. Br J Haem 2001;115:140–144. [DOI] [PubMed] [Google Scholar]
- 4. Escoffre‐Barbe M, Oger E, Leroyer C, et al. Evaluation of a new rapid D‐dimer assay for clinically suspected deep venous thrombosis (Liatest D‐dimer). Am J Clin Pathol 1998;109:748–753. [DOI] [PubMed] [Google Scholar]
- 5. Wilde JT, Kitchen S, Kinsey S, Greaves M, Preston FE. Plasma D‐dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states. Br J Haem 1989;71:65–70. [DOI] [PubMed] [Google Scholar]
- 6. Flores J, Lancha C, Rodriguez EP, Avello AG, Bollo E, Frade LJG. Efficacy of D‐dimer and total fibrin degradation products evaluation in suspected pulmonary embolism. Respiration 1995;62:258–262. [DOI] [PubMed] [Google Scholar]
- 7. Perrier A, Desmarais S, Goehring C, et al. D‐dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med 1997;156:492–496. [DOI] [PubMed] [Google Scholar]
- 8. Oger E, Leroyer C, Bressollette L, et al. Evaluation of a new, rapid and quantitative D‐dimer test in patients with suspected pulmonary embolism. Am J Respir Crit Care Med 1998;158:65–70. [DOI] [PubMed] [Google Scholar]
- 9. Duet M, Benelhadj S, Kedra W, et al. A new quantitative D‐dimer assay appropriate in emergency: reliability of the assay for pulmonary embolism exclusion diagnosis. Thromb Res 1998;91:1–5. [DOI] [PubMed] [Google Scholar]
- 10. Bounameaux H, Cirafici P, de Moerloose P, et al. Measurement of D‐dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet 1991;337:196–200. [DOI] [PubMed] [Google Scholar]
- 11. Keeling DM, Wright M, Baker P, Sackett D. D‐dimer for the exclusion of venous thromboembolism: comparison of a new automated latex particle immunoassay (MDA D‐dimer) with an established enzyme‐linked fluorescent assay (VIDAS D‐dimer). Clin Lab Haem 1999;21:359–362. [DOI] [PubMed] [Google Scholar]